A Rare Disease. A Race for Treatments
We’re bringing families, scientists, and supporters together to accelerate research and develop life-changing treatments for FARS2 deficiency, an ultra-rare genetic disease.
Advancing Research, Accelerating Breakthroughs
FARS2 deficiency causes progressive neurological disability, profoundly affecting children and families. Today, advances in genetic medicine and drug repurposing offer new opportunities to develop effective treatments. We're working to turn these possibilities into reality. Our goal goes beyond FARS2: By sharing knowledge, we hope to accelerate breakthroughs that can benefit people living with thousands of other rare genetic disorders.
GENE THERAPY
We're working with leading researchers to develop a gene therapy that addresses the underlying cause of FARS2 deficiency. We aim to move promising treatments from research toward clinical trials.
Our Strategy
DRUG REPURPOSING
Existing medications may offer a faster path to treatment. We're investigating drugs already approved or studied for other conditions to identify any that could improve cellular function and slow the progression of FARS2 deficiency.
IMPROVED MOBILITY
We're exploring technologies and therapies that can help people with FARS2 deficiency maintain mobility. We aim to improve quality of life while longer-term treatments are developed.
Stronger Together.
Connecting FARS2 Families, Researchers, and Clinicians
FARS2 deficiency is so rare that families often face the disease in isolation, with few answers and limited treatment options. We're building a network of families, scientists, and clinicians to change that — accelerate progress toward effective treatments.